Our data suggests a potential link between differential GPR15 expression and altered composition of both innate and adaptive immune subsets in human CRC depending on disease status (tumor compared to ‘normal’ tumor-margin) with a marked shift towards certain inflammatory, immune-suppressive effector phenotypes, such as elevated IL-17-expressing CD4+ T cells in tumor tissues. The gene discussed is CD4; the disease is colorectal carcinoma.